|

A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

RECRUITINGPhase 2Sponsored by Alnylam Pharmaceuticals
Actively Recruiting
PhasePhase 2
SponsorAlnylam Pharmaceuticals
Started2026-08-17
Est. completion2030-05-18
Eligibility
Age40 Years – 55 Years
Healthy vol.Accepted
Locations4 sites

Summary

The purpose of the study is to evaluate the effect of mivelsiran in adult participants with early-stage DS-AD and to characterize the safety, tolerability, and pharmacodynamics (PD) of mivelsiran. The study will be conducted over 2 periods: a 24-month double-blind period and an optional 12-month open-label treatment extension (OLE) period. The estimated duration of study participation, inclusive of screening, treatment, and additional safety follow-up, is up to 39 months.

Eligibility

Age: 40 Years – 55 YearsHealthy volunteers accepted
Inclusion Criteria:

* Clinical diagnosis of Down-Syndrome (DS) associated with trisomy 21
* Positive amyloid PET scan
* Cognitively stable in the opinion of the investigator
* Seizures must be well controlled with no occurrence of seizures in the 6 months prior to screening

Exclusion Criteria:

* Has severe intellectual disability (ID)
* Has a history of DS regression disorder
* Has alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>2×upper limit of normal (ULN) at Screening
* Has estimated glomerular filtration rate (eGFR) \<45 mL/min/1.73m\^2 at Screening
* Has recently received an investigational agent
* Has had treatment with amyloid-targeting antibody
* Comorbidities such as obstructive sleep apnea and hypothyroidism that are not well controlled

Note: other protocol defined inclusion / exclusion criteria apply

Conditions2

Alzheimer's DiseaseDown Syndrome-Associated Alzheimer's Disease (DS-AD)

Interventions1

Locations4 sites

Florida

2 sites
Clinical Trial Site
Maitland, Florida, 32751
Clinical Trial Site
Naples, Florida, 34105

Indiana

1 site
Clinical Trial Site

Missouri

1 site
Clinical Trial Site
St Louis, Missouri, 63110

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.